Product Code: A10885
The global biomedical warming and thawing devices market was valued at $159.3 million in 2021, and is projected to reach $376.7 million by 2031, registering a CAGR of 9.1% from 2022 to 2031. Biomedical warming and thawing devices are typically used to defrost samples of blood, tissues, cells, and other biologics. Cryopreservation is known as a method of successfully and safely preserving cells and tissues at a lower temperature, often below freezing point. It is therefore necessary to defrost these biological products before use, and in this case, biomedical warming and thawing equipment play a crucial role by assisting in the warming and defrosting of cryopreserved products.
They also reduce the possibility that cryo-preservative chemicals would harm these objects, as extended exposure to such chemicals might impair the preserved materials' living cells and other components. For stored cells to remain effective and viable for use in medical procedures, the use of biomedical warming and thawing devices is essential.
The biomedical warming and thawing devices market is anticipated to develop as more cryopreservation techniques are used to preserve cells and tissues. Increased demand for automated biomedical warming and thawing equipment is also helping the market grow. Growing need for pharmaceutical research is also anticipated to boost the rate of adoption for biomedical warming and thawing devices, thus, driving the market growth during the forecast period. The biomedical warming and thawing devices market is driven by rise in the number of blood banks and blood infusion centers, numerous advantages offered by automatic biomedical warming and thawing devices, and increase in the number of road accidents and trauma cases leading to blood transfusions. Biomedical warming and thawing devices are used in blood bank for preservation of plasma, stem cells, whole blood & RBCs (red blood cells), and platelets. Thus, increase in the number of blood banks and blood infusion centers is anticipated to drive the market growth.
Moreover, surge in demand for blood donation causes increase in the usage of warming and thawing devices for preservation of blood. Thus, this factor is anticipated to fuel the growth of the market. For instance, according to the World Health Organization, in 2020, globally, 118.5 million blood donations are collected each year. Around 85 million units of blood are given to patients each year. As per the same source, up to 54% of blood transfusions were given to children under 5 years of age in low-income countries; whereas, the most frequently transfused patient group was over 60 years of age, accounting for up to 75% of all transfusions in high-income countries.
Biomedical warming and thawing devices have a wide range of applications in pharmaceutical and biotechnology field for various research and studies, tissue culturing, and animal & plant engineering. Moreover, surge in number of patients for admission in medical emergency departments and rise in the number of road traffic accidents resulting in need of blood transfusion. Thus, these factors increase the demand for biomedical warming and thawing devices, which fuels the market growth. In addition, technological advancement in the healthcare sector and rise in R&D activities drive the growth of the biomedical warming and thawing devices market. On the other hand, strict regulation related to thawed biomedical products and samples and use of cryopreserved are anticipated to hinder the growth of the market. In addition, technical concerns, such as low survival biomaterial sample loss of cellular characteristics, altered gene expression, epigenic changes, and shift in protein composition are expected to limit the growth of the biomedical warming and thawing devices market.
The biomedical warming and thawing devices market is segmented on the basis of product, sample, end user, and region. On the basis of product, the market is segmented into manual and automatic. On the basis of sample market is segmented into blood products, stem cells, embryo, ovum, and others. Blood products is further bifurcated into plasma, & RBCs. By end user, the market is bifurcated into biotechnology & pharmaceutical companies, hospitals & diagnostic laboratories, and blood banks & stem cell banks. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global biomedical warming and thawing devices market include, Barkey GmbH & co. kg, Boekel Scientific, Cardinal Health, Conroy Medical AB., Cytiva, CytoTherm, Eppendorf, Farrar Scientific, Fisher Scientific PTE LTD (Thermo Fisher Scientific), FreMon Scientific, Inc., GE, Helmer Scientific, KW Apparecchi Scientifici, Sarstedt AG & Co. KG, Sartorius AG, and Thaw World Medical Ltd.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the biomedical warming and thawing devices market analysis from 2021 to 2031 to identify the prevailing biomedical warming and thawing devices market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the biomedical warming and thawing devices market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global biomedical warming and thawing devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
By Sample Type
- Blood Product
- Stem cell
- Embryo
- Ovum
- Others
By End User
- Hospitals and Diagnostic Laboratories
- Biotechnology and Pharmaceutical Companies
- Blood Banks and stem cell banks
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Barkey gmbh and co. kg
- BioLife Solutions
- BOEKEL SCIENTIFIC
- CARDINAL HEALTH
- Conroy Medical AB.
- Cytiva
- CytoTherm
- Eppendorf
- Farrar Scientific
- FISHER SCIENTIFIC PTE LTD
- FreMon Scientific, Inc.
- Helmer Scientific
- KW APPARECCHI SCIENTIFICI
- Sarstedt AG and Co. KG
- Sartorius AG
- ThawWorld Medical Ltd.
- General Electric Company
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter's five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Manual
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Automatic
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
CHAPTER 5: BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY SAMPLE TYPE
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Blood Product
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.2.4 Blood Product Biomedical Warming and Thawing Devices Market by Type
- 5.2.4.1 Plasma Market size and forecast, by region
- 5.2.4.2 RBC Market size and forecast, by region
- 5.3 Stem cell
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Embryo
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Ovum
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- 5.6 Others
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country
CHAPTER 6: BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Biotechnology and Pharmaceutical Companies
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Hospitals and Diagnostic Laboratories
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Blood Banks and stem cell banks
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
CHAPTER 7: BIOMEDICAL WARMING AND THAWING DEVICES MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
- 7.2.3 North America Market size and forecast, by Sample Type
- 7.2.3.1 North America Blood Product Biomedical Warming and Thawing Devices Market by Type
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Product
- 7.2.5.1.2 Market size and forecast, by Sample Type
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Product
- 7.2.5.2.2 Market size and forecast, by Sample Type
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Product
- 7.2.5.3.2 Market size and forecast, by Sample Type
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
- 7.3.3 Europe Market size and forecast, by Sample Type
- 7.3.3.1 Europe Blood Product Biomedical Warming and Thawing Devices Market by Type
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Product
- 7.3.5.1.2 Market size and forecast, by Sample Type
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Product
- 7.3.5.2.2 Market size and forecast, by Sample Type
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 UK
- 7.3.5.3.1 Market size and forecast, by Product
- 7.3.5.3.2 Market size and forecast, by Sample Type
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Product
- 7.3.5.4.2 Market size and forecast, by Sample Type
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Product
- 7.3.5.5.2 Market size and forecast, by Sample Type
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Product
- 7.3.5.6.2 Market size and forecast, by Sample Type
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
- 7.4.3 Asia-Pacific Market size and forecast, by Sample Type
- 7.4.3.1 Asia-Pacific Blood Product Biomedical Warming and Thawing Devices Market by Type
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 China
- 7.4.5.1.1 Market size and forecast, by Product
- 7.4.5.1.2 Market size and forecast, by Sample Type
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 Japan
- 7.4.5.2.1 Market size and forecast, by Product
- 7.4.5.2.2 Market size and forecast, by Sample Type
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Product
- 7.4.5.3.2 Market size and forecast, by Sample Type
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 Australia
- 7.4.5.4.1 Market size and forecast, by Product
- 7.4.5.4.2 Market size and forecast, by Sample Type
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 Rest of Asia-Pacific
- 7.4.5.5.1 Market size and forecast, by Product
- 7.4.5.5.2 Market size and forecast, by Sample Type
- 7.4.5.5.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
- 7.5.3 LAMEA Market size and forecast, by Sample Type
- 7.5.3.1 LAMEA Blood Product Biomedical Warming and Thawing Devices Market by Type
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Product
- 7.5.5.1.2 Market size and forecast, by Sample Type
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Product
- 7.5.5.2.2 Market size and forecast, by Sample Type
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Product
- 7.5.5.3.2 Market size and forecast, by Sample Type
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Product
- 7.5.5.4.2 Market size and forecast, by Sample Type
- 7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
CHAPTER 9: COMPANY PROFILES
- 9.1 Barkey gmbh and co. kg
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 BioLife Solutions
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 BOEKEL SCIENTIFIC
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 CARDINAL HEALTH
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Conroy Medical AB.
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 Cytiva
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 CytoTherm
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Eppendorf
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Farrar Scientific
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 FISHER SCIENTIFIC PTE LTD
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- 9.11 FreMon Scientific, Inc.
- 9.11.1 Company overview
- 9.11.2 Company snapshot
- 9.11.3 Operating business segments
- 9.11.4 Product portfolio
- 9.11.5 Business performance
- 9.11.6 Key strategic moves and developments
- 9.12 Helmer Scientific
- 9.12.1 Company overview
- 9.12.2 Company snapshot
- 9.12.3 Operating business segments
- 9.12.4 Product portfolio
- 9.12.5 Business performance
- 9.12.6 Key strategic moves and developments
- 9.13 KW APPARECCHI SCIENTIFICI
- 9.13.1 Company overview
- 9.13.2 Company snapshot
- 9.13.3 Operating business segments
- 9.13.4 Product portfolio
- 9.13.5 Business performance
- 9.13.6 Key strategic moves and developments
- 9.14 Sarstedt AG and Co. KG
- 9.14.1 Company overview
- 9.14.2 Company snapshot
- 9.14.3 Operating business segments
- 9.14.4 Product portfolio
- 9.14.5 Business performance
- 9.14.6 Key strategic moves and developments
- 9.15 Sartorius AG
- 9.15.1 Company overview
- 9.15.2 Company snapshot
- 9.15.3 Operating business segments
- 9.15.4 Product portfolio
- 9.15.5 Business performance
- 9.15.6 Key strategic moves and developments
- 9.16 ThawWorld Medical Ltd.
- 9.16.1 Company overview
- 9.16.2 Company snapshot
- 9.16.3 Operating business segments
- 9.16.4 Product portfolio
- 9.16.5 Business performance
- 9.16.6 Key strategic moves and developments
- 9.17 General Electric Company
- 9.17.1 Company overview
- 9.17.2 Company snapshot
- 9.17.3 Operating business segments
- 9.17.4 Product portfolio
- 9.17.5 Business performance
- 9.17.6 Key strategic moves and developments